Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Certain drugs that block specific enzymes can help treat prostate diseases.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Mutations in certain receptors can cause diseases and offer new treatment options.

A mouse gene mutation increases the risk of skin cancer.

People undergoing chemotherapy need better support and information to cope with hair loss.

Overexpression of HDGF in melanocytes does not cause cancer.

The research showed how melanocytes develop, move, and respond to UV light, and their stem cells' role in hair color and skin cancer risk.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Adding a second method to PROTACs could improve cancer treatment.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

Chemotherapy and radiation therapy cause skin and hair damage by altering gene expression and signaling pathways.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.